Literature DB >> 12558151

Diferuloylmethane inhibits neutrophil infiltration and improves survival of mice in high-dose endotoxin shock.

Babita Madan1, Balaram Ghosh.   

Abstract

Gram-negative septic shock is a systemic inflammatory response of the body caused primarily by the cell wall component (lipopolysaccharide) of the gram-negative bacteria. During high-dose endotoxin shock, neutrophils infiltrate and accumulate in the liver, causing hepatocellular injury. Cell adhesion molecules, specifically intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1), play an important role in the infiltration of neutrophils in the liver tissue. In this study, we demonstrate that diferuloylmethane exerts protective effect in high-dose endotoxin shock by improving survival and reducing the severity of endotoxin shock symptoms such as lethargy, diarrhea, and watery eyes following a challenge with lipopolysaccharide. We demonstrate here that diferuloylmethane inhibits the transmigration and infiltration of neutrophils from blood vessels to the underlying liver tissue and, hence, inhibits the damage to the tissue. Diferuloylmethane blocks the induced expression of ICAM-1 and VCAM-1 in liver and lungs. Diferuloylmethane, being a natural compound, may have few side effects and may be useful in attenuating multiple organ injury in pathological conditions arising due to excessive infiltration of neutrophils into the tissues.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12558151     DOI: 10.1097/00024382-200301000-00017

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  8 in total

1.  Dietary curcumin increases antioxidant defenses in lung, ameliorates radiation-induced pulmonary fibrosis, and improves survival in mice.

Authors:  James C Lee; Paul A Kinniry; Evguenia Arguiri; Matthew Serota; Stathis Kanterakis; Shampa Chatterjee; Charalambos C Solomides; Prashanthi Javvadi; Constantinos Koumenis; Keith A Cengel; Melpo Christofidou-Solomidou
Journal:  Radiat Res       Date:  2010-05       Impact factor: 2.841

Review 2.  Polyphenols in the treatment of inflammatory bowel disease and acute pancreatitis.

Authors:  Haim Shapiro; Pierre Singer; Zamir Halpern; Rafael Bruck
Journal:  Gut       Date:  2006-08-24       Impact factor: 23.059

3.  Inhibition of oxidative stress and cytokine activity by curcumin in amelioration of endotoxin-induced experimental hepatoxicity in rodents.

Authors:  G Kaur; N Tirkey; S Bharrhan; V Chanana; P Rishi; K Chopra
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

4.  Intranasal curcumin ameliorates lipopolysaccharide-induced acute lung injury in mice.

Authors:  Asha Kumari; Namitosh Tyagi; D Dash; Rashmi Singh
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

5.  Curcumin inhibits lipopolysaccharide (LPS)-induced endotoxemia and airway inflammation through modulation of sequential release of inflammatory mediators (TNF-α and TGF-β1) in murine model.

Authors:  Asha Kumari; D Dash; Rashmi Singh
Journal:  Inflammopharmacology       Date:  2017-03-13       Impact factor: 4.473

6.  Protective effect of curcumin against liver warm ischemia/reperfusion injury in rat model is associated with regulation of heat shock protein and antioxidant enzymes.

Authors:  Shi-Qiang Shen; Yuan Zhang; Jin-Jian Xiang; Cheng-Long Xiong
Journal:  World J Gastroenterol       Date:  2007-04-07       Impact factor: 5.742

Review 7.  Immunosuppressive Effects of Natural α,β-Unsaturated Carbonyl-Based Compounds, and Their Analogs and Derivatives, on Immune Cells: A Review.

Authors:  Laiba Arshad; Ibrahim Jantan; Syed Nasir Abbas Bukhari; Md Areeful Haque
Journal:  Front Pharmacol       Date:  2017-01-30       Impact factor: 5.810

8.  Suppression of experimental choroidal neovascularization by curcumin in mice.

Authors:  Ping Xie; WeiWei Zhang; Songtao Yuan; Zhiqiang Chen; Qin Yang; DongQing Yuan; Feng Wang; QingHuai Liu
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.